PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders

S Jamwal, JK Blackburn, JD Elsworth - Pharmacology & Therapeutics, 2021 - Elsevier
Neurodegenerative diseases represent some of the most devastating neurological
disorders, characterized by progressive loss of the structure and function of neurons. Current …

[HTML][HTML] PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease

JC Corona, MR Duchen - Free Radical Biology and Medicine, 2016 - Elsevier
There is increasing evidence for the involvement of mitochondrial dysfunction and oxidative
stress in the pathogenesis of many of the major neurodegenerative and neuroinflammatory …

RETRACTED: Activation of the PPAR/PGC-1α Pathway Prevents a Bioenergetic Deficit and Effectively Improves a Mitochondrial Myopathy Phenotype

T Wenz, F Diaz, BM Spiegelman, CT Moraes - Cell metabolism, 2008 - cell.com
Neuromuscular disorders with defects in the mitochondrial ATP-generating system affect a
large number of children and adults worldwide, but remain without treatment. We used a …

Mitochondrial biogenesis in neurodegeneration

PA Li, X Hou, S Hao - Journal of neuroscience research, 2017 - Wiley Online Library
Mitochondria play a key role in energy production, calcium homeostasis, cell survival, and
death. Adverse stimulations including neurodegenerative diseases may result in …

PGC-1α, mitochondrial dysfunction, and Huntington's disease

A Johri, A Chandra, MF Beal - Free Radical Biology and Medicine, 2013 - Elsevier
The constant high energy demand of neurons makes them rely heavily on their
mitochondria. Dysfunction of mitochondrial energy metabolism leads to reduced ATP …

PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond

T Tsunemi, AR La Spada - Progress in neurobiology, 2012 - Elsevier
Neurons are specialized cells with unique features, including a constant high demand for
energy. Mitochondria satisfy this constant demand, and are emerging as a central target for …

PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders

J Lv, S Jiang, Z Yang, W Hu, Z Wang, T Li… - Ageing research reviews, 2018 - Elsevier
Recently, growing evidence has demonstrated that peroxisome proliferator activated
receptor γ (PPARγ) coactivator-1α (PGC-1α) is a superior transcriptional regulator that acts …

PPAR: a therapeutic target in Parkinson's disease

RK Chaturvedi, MF Beal - Journal of neurochemistry, 2008 - Wiley Online Library
Parkinson's disease (PD) is a progressive and chronic neurodegenerative disorder,
characterized by progressive loss of dopaminergic neurons in substantia nigra. The etiology …

PPARγ and PGC-1α as therapeutic targets in Parkinson's

JC Corona, MR Duchen - Neurochemical research, 2015 - Springer
The peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-activated
transcriptional factor that belongs to the nuclear hormone receptor superfamily. PPARγ was …

Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target

YN Yang, MQ Zhang, FL Yu, B Han, MY Bao… - Biochemical …, 2023 - Elsevier
Neurodegenerative disorders (NDDs) are characterized by progressive loss of selectively
vulnerable neuronal populations and myelin sheath, leading to behavioral and cognitive …